Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dysfunction of neuronal calcium signalling in neuroinflammation and neurodegeneration.
The Use of Fourth-generation Optical Coherence Tomography in Multiple Sclerosis: A Review.
A Psychometric Validation of Two Brief Measures to Assess Palliative Need in Patients Severely Affected by Multiple Sclerosis.
Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis.
Multiple sclerosis: individualized disease susceptibility and therapy response.
Acceptance of pain in neurological disorders: Associations with functioning and psychosocial well-being.
Anti-IL-17A Treatment Reduces Clinical Score and VCAM-1 Expression Detected by in Vivo Magnetic Resonance Imaging in CR-EAE ABH Mice.
Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate.
Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis.
African ancestry is a predictor factor to secondary progression in clinical course of multiple sclerosis.
Improving adherence to injectable disease-modifying drugs in multiple sclerosis.
Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.
MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentary.
CD21 positive B cell: A novel target for treatment of multiple sclerosis.
Seronegative NMO: A sensitive AQP4 antibody test clarifies clinical features and next challenges.
Association of innate immune activation with latent Epstein-Barr virus in active MS lesions.
Structural and Functional Abnormalities of the Neuromuscular Junction in the Trembler-J Homozygote Mouse Model of Congenital Hypomyelinating Neuropathy.
Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder.
Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008-2012.
Patulous eustachian tube after percutaneous balloon microcompression for trigeminal neuralgia: case report.
Rehabilitation interventions for the management of multiple sclerosis relapse: a short scoping review.
Learning a cost function for microscope image segmentation.
Phase imaging in brain using SWIFT.
Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disability.
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients.
Pages
« first
‹ previous
…
434
435
436
437
438
439
440
441
442
…
next ›
last »